Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints

Elias Laurin Meyer, Peter Mesenbrink, Nicholas A. Di Prospero +5

Non-alcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD) and a disease with high unmet medical need. Platform trials provide great b…